John Tazare Profile
John Tazare

@JohnTStats

Followers
364
Following
603
Media
14
Statuses
128

Assistant Professor @LSHTM. Biostatistics PhD.

London, England
Joined January 2017
Don't wanna be here? Send us removal request.
@Patient_Data
Understanding Patient Data
1 year
UPD countdown to Christmas day 7/15: New guest blog! 🎄 In today’s UPD guest blog, @JohnTStats and Helen Strongman from @ehr_lshtm share their research and discuss their perspectives on the impact of opt-outs on health research. Read below!👇
Tweet card summary image
understandingpatientdata.org.uk
Understanding Patient Data supports conversations with the public, patients and healthcare professionals about the uses of health information for care and research.
0
1
0
@JohnTStats
John Tazare
1 year
🚨Our paper on National data opt-outs in 2021 is out in @BJGPOpen !
@BJGPOpen
BJGP Open Journal
1 year
The English NHS data opt-out allows people to prevent use of their health data other than for direct care. Tazare+al describe how opt-outs varied in 2021 by key demographic characteristics, and discuss statistical and epidemiological implications ➡️ https://t.co/00n7x0YpPo
0
1
3
@BMJ_Open
BMJ_Open
1 year
Changes in sick notes associated with COVID-19 from 2020 to 2022: a cohort study in 24 million primary care patients in OpenSAFELY-TPP https://t.co/z23h3sLZLr @anschaf @johntstats
0
2
1
@CAUSALab
CAUSALab
2 years
The 17th Kolokotrones Symposium, "UK Secure Data Environments: A New Approach to Population-Scale Real World Evidence,” was a success! Thanks to our speakers for providing valuable insight into the British data model. Presentations now live on YouTube: https://t.co/68ixgBgIMH
1
5
30
@CAUSALab
CAUSALab
2 years
Halfway through our morning sessions at @CAUSALab's #KolokronesSyposium! Now we're learning from @JohnTStats, Statistical Pharmacoepidemiologist at @LSHTM who is presenting on #Causalinference for #therapeutics: OpenSAFELY and #COVID19.
0
2
12
@LSHTMrdm
LSHTM Research Data
2 years
Looking forward to this @HarvardChanSPH event on Secure Data Environments for medical data & electronic health records, which features a talk from LSHTM's @JohnTStats
Tweet card summary image
hsph.harvard.edu
Time
0
3
2
@AnnaTheresia
Anna Schultze
2 years
Very exciting to see code sharing forming part of the BMJ's new data sharing policy (and not just for trials!). Will be interesting to see how this is implemented and followed 👀
@KamranAbbasi
Kamran Abbasi
2 years
A major new announcement: Mandatory data and code sharing for research published by The BMJ @bmj_latest
0
2
6
@JohnTStats
John Tazare
2 years
The BMJ's policy, alongside other open research indicators, could be monitored with a new "open research" tag at the end of manuscripts which might encourage the reporting of other important transparency indicators in a standardised way - e.g., pre-registration and pre-printing.
0
0
1
@JohnTStats
John Tazare
2 years
@AnnaTheresia and I highlight that, as epidemiologists, much of our research involves the use of data for which sharing is not a legal possibility. Therefore, programming code sharing has an important role in improving the transparency of this research.
1
1
0
@LSHTM_datastats
Data & Statistical Science for Health, LSHTM
2 years
🔊 Our Early Career Researcher Showcase! Join us for an exciting hybrid event on Nov 7th, featuring LSHTM's emerging talents in data and statistical science. Nominate yourself or a colleague by completing the form before the Oct 13th deadline. 👇 https://t.co/tbXcX0Mb3E
0
7
4
@JohnTStats
John Tazare
2 years
🚨Want to apply the high-dimensional propensity score algorithm? As well as great software available in SAS and R, there's now a dedicated Stata package for implementing these approaches! https://t.co/xsFZ0vk5H3
0
4
27
@LSHTM_datastats
Data & Statistical Science for Health, LSHTM
2 years
Join us for inaugural lectures from Jonathan Bartlett, Ruth Keogh and Fizz Williamson "Please mind the methodology gap: biostatistics to the rescue" 📅Thurs 14 September 🕔17:15 UK GMT +1 [BST] 📍LSHTM & online 🔗 https://t.co/gg1CwGS4qO
2
23
59
@DaviesGwyneth
Gwyneth Davies
2 years
Delighted to see our commentary published, outlining the potential for trial emulation with observational data from #CysticFibrosis (CF) registries. By @RuthHKeogh and I on behalf of the CF trial emulation network (CF-TEN)
0
5
15
@AnnaTheresia
Anna Schultze
2 years
At #ICPE23 and interested in open science? Come to our symposium, “Sharing is Caring?”, about the sharing of programming code in pharmacoepidemiology at 4.15 in MR201! We’ll have review results, examples and live polls ✨@JohnTStats @Shirley_Wang_V @prieto_alhambra
0
3
12
@LSHTM
London School of Hygiene & Tropical Medicine
2 years
New study shows among people with blood sugar levels below threshold for diabetes: Men with raised blood sugar had 30% greater risk of developing cardiovascular diseases (CVDs) Women with raised blood sugar had 30-50% greater risk of developing CVDs📈👥
1
14
22
@Roxytonin
LaurieTomlinson
2 years
We know the #COVID pandemic disrupted healthcare but did it exacerbate ethnic differences in chronic disease monitoring? A quick dive into a recent @OpenSAFELY @COVID19_LHW @ehr_lshtm paper led by @RcostelloEpi @Ladyroho and @sineadlangan_1 https://t.co/anb5vu04AC
1
11
25
@JohnTStats
John Tazare
2 years
Great academic/industry collaboration working with colleagues at @ehr_lshtm, @GSK and @analysisgroup
0
0
0
@JohnTStats
John Tazare
2 years
Reviewing initial applications of a novel methodological proposal allowed us to understand current practice whilst identifying gaps in methodological knowledge and potential barriers to wider uptake.
1
0
0